SynAgile Completes Enrollment of its Phase 2 Clinical Trial

SAN JOSE, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) -- SynAgile Corporation (www.SynAgile.com) is pleased to announce it has completed enrollment of its...

Related Keywords

Luxembourg ,Italy ,California ,United States ,Spain ,Ephraim Heller ,Synagile Corporation ,Agile Corporation ,Dopafuse Delivery System ,Continuous Oral Levodopa ,Dopafuse System ,San Jose ,Chief Executive ,